Oral Biologics & Biosimilar Drugs Global Market Report 2023
Oral Biologics & Biosimilar Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on oral biologics & biosimilar drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for oral biologics & biosimilar drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral biologics & biosimilar drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered: 1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors
2) By Disease: Asthma; Crohn'S Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarcoma; Psoriasis and Others
3) By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies; Other Molecule Types
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Novartis; Rani Therapeutics; Eli Lilly and Co.; AstraZeneca plc; Novo Nordisk A/S
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Executive Summary
- 2. Oral Biologics & Biosimilars Market Characteristics
- 3. Oral Biologics & Biosimilars Market Trends And Strategies
- 4. Oral Biologics & Biosimilars Market – Macro Economic Scenario
- 4.1 COVID-19 Impact On Oral Biologics & Biosimilars Market
- 4.2 Ukraine-Russia War Impact On Oral Biologics & Biosimilars Market
- 4.3 Impact Of High Inflation On Oral Biologics & Biosimilars Market
- 5. Oral Biologics & Biosimilars Market Size And Growth
- 5.1. Global Oral Biologics & Biosimilars Historic Market, 2017-2022, $ Billion
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints On The Market
- 5.2. Global Oral Biologics & Biosimilars Forecast Market, 2022-2027F, 2032F, $ Billion
- 5.2.1. Drivers Of The Market
- 5.2.2. Restraints On the Market
- 6. Oral Biologics & Biosimilars Market Segmentation
- 6.1. Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Lymphocyte Modulators
- Interleukin Inhibitors
- Tumor Necrosis Factor-Alpha Inhibitors
- 6.2. Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Asthma
- Crohn'S Disease
- Carcinoma
- Arthritis
- Diabetes
- Multiple Myeloma
- Enterocolitis
- Multiple Sclerosis
- Sarcoma
- Psoriasis and Others
- 6.3. Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Vaccines
- Proteins & Peptides
- Monoclonal Antibodies
- Other Molecule Types
- 6.4. Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 7. Oral Biologics & Biosimilars Market Regional And Country Analysis
- 7.1. Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 7.2. Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8. Asia-Pacific Oral Biologics & Biosimilars Market
- 8.1. Asia-Pacific Oral Biologics & Biosimilars Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 9. China Oral Biologics & Biosimilars Market
- 9.1. China Oral Biologics & Biosimilars Market Overview
- 9.2. China Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 10. India Oral Biologics & Biosimilars Market
- 10.1. India Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11. Japan Oral Biologics & Biosimilars Market
- 11.1. Japan Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12. Australia Oral Biologics & Biosimilars Market
- 12.1. Australia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13. Indonesia Oral Biologics & Biosimilars Market
- 13.1. Indonesia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14. South Korea Oral Biologics & Biosimilars Market
- 14.1. South Korea Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15. Western Europe Oral Biologics & Biosimilars Market
- 15.1. Western Europe Oral Biologics & Biosimilars Market Overview
- 15.2. Western Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16. UK Oral Biologics & Biosimilars Market
- 16.1. UK Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17. Germany Oral Biologics & Biosimilars Market
- 17.1. Germany Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18. France Oral Biologics & Biosimilars Market
- 18.1. France Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19. Eastern Europe Oral Biologics & Biosimilars Market
- 19.1. Eastern Europe Oral Biologics & Biosimilars Market Overview
- 19.2. Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20. Russia Oral Biologics & Biosimilars Market
- 20.1. Russia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21. North America Oral Biologics & Biosimilars Market
- 21.1. North America Oral Biologics & Biosimilars Market Overview
- 21.2. North America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22. USA Oral Biologics & Biosimilars Market
- 22.1. USA Oral Biologics & Biosimilars Market Overview
- 22.2. USA Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23. South America Oral Biologics & Biosimilars Market
- 23.1. South America Oral Biologics & Biosimilars Market Overview
- 23.2. South America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24. Brazil Oral Biologics & Biosimilars Market
- 24.1. Brazil Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25. Middle East Oral Biologics & Biosimilars Market
- 25.1. Middle East Oral Biologics & Biosimilars Market Overview
- 25.2. Middle East Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26. Africa Oral Biologics & Biosimilars Market
- 26.1. Africa Oral Biologics & Biosimilars Market Overview
- 26.2. Africa Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27. Oral Biologics & Biosimilars Market Competitive Landscape And Company Profiles
- 27.1. Oral Biologics & Biosimilars Market Competitive Landscape
- 27.2. Oral Biologics & Biosimilars Market Company Profiles
- 27.2.1. Novartis
- 27.2.1.1. Overview
- 27.2.1.2. Products and Services
- 27.2.1.3. Strategy
- 27.2.1.4. Financial Performance
- 27.2.2. Rani Therapeutics
- 27.2.2.1. Overview
- 27.2.2.2. Products and Services
- 27.2.2.3. Strategy
- 27.2.2.4. Financial Performance
- 27.2.3. Eli Lilly and Co.
- 27.2.3.1. Overview
- 27.2.3.2. Products and Services
- 27.2.3.3. Strategy
- 27.2.3.4. Financial Performance
- 27.2.4. AstraZeneca plc
- 27.2.4.1. Overview
- 27.2.4.2. Products and Services
- 27.2.4.3. Strategy
- 27.2.4.4. Financial Performance
- 27.2.5. Novo Nordisk A/S
- 27.2.5.1. Overview
- 27.2.5.2. Products and Services
- 27.2.5.3. Strategy
- 27.2.5.4. Financial Performance
- 28. Oral Biologics & Biosimilars Pipeline Analysis
- 29. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market
- 30. Oral Biologics & Biosimilars Market Future Outlook and Potential Analysis
- 31. Appendix
- 31.1. Abbreviations
- 31.2. Currencies
- 31.3. Historic And Forecast Inflation Rates
- 31.4. Research Inquiries
- 31.5. The Business Research Company
- 31.6. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook